WO2011073995A3 - Liquid vaginal spray of progesterone - Google Patents

Liquid vaginal spray of progesterone Download PDF

Info

Publication number
WO2011073995A3
WO2011073995A3 PCT/IN2010/000790 IN2010000790W WO2011073995A3 WO 2011073995 A3 WO2011073995 A3 WO 2011073995A3 IN 2010000790 W IN2010000790 W IN 2010000790W WO 2011073995 A3 WO2011073995 A3 WO 2011073995A3
Authority
WO
WIPO (PCT)
Prior art keywords
progesterone
vaginal spray
liquid vaginal
liquid
solvent
Prior art date
Application number
PCT/IN2010/000790
Other languages
French (fr)
Other versions
WO2011073995A2 (en
Inventor
Rajni Gulabdas Patel
Jigar Hasmukhbhai Patel
Arun Chimanlal Shah
Shardul Arunkumar Naik
Original Assignee
Lincoln Pharmaceuticals Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lincoln Pharmaceuticals Limited filed Critical Lincoln Pharmaceuticals Limited
Publication of WO2011073995A2 publication Critical patent/WO2011073995A2/en
Publication of WO2011073995A3 publication Critical patent/WO2011073995A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams

Abstract

Disclosed herein a liquid vaginal spray composition comprising natural/synthetic progesterone along with unique blend of solvent/co-solvent and anti-oxidants useful for treating secondary amenorrhea, threatened or habitual abortions and infertility.
PCT/IN2010/000790 2009-12-14 2010-12-06 Liquid vaginal spray of progesterone WO2011073995A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2879MU2009 2009-12-14
IN2879/MUM/2009 2009-12-14

Publications (2)

Publication Number Publication Date
WO2011073995A2 WO2011073995A2 (en) 2011-06-23
WO2011073995A3 true WO2011073995A3 (en) 2011-08-11

Family

ID=43971502

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2010/000790 WO2011073995A2 (en) 2009-12-14 2010-12-06 Liquid vaginal spray of progesterone

Country Status (1)

Country Link
WO (1) WO2011073995A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9248136B2 (en) 2011-11-23 2016-02-02 Therapeuticsmd, Inc. Transdermal hormone replacement therapies

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
KR20170005819A (en) 2014-05-22 2017-01-16 쎄러퓨틱스엠디, 인코퍼레이티드 Natural combination hormone replacement formulations and therapies
JP2017523138A (en) 2014-07-29 2017-08-17 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． Transdermal cream
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
AU2017239645A1 (en) 2016-04-01 2018-10-18 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4252787A (en) * 1976-12-27 1981-02-24 Cambridge Research And Development Group Anti-fertility composition and method
US20050181045A1 (en) * 1998-11-18 2005-08-18 Ferring Pharmaceuticals, Inc. Vaginally administrable progesterone-containing tablets and method for preparing same
WO2006060462A1 (en) * 2004-12-01 2006-06-08 Johnson & Johnson Consumer Companies, Inc. Compositions and methods of treating irritation and kit therefor
WO2006131784A1 (en) * 2004-04-28 2006-12-14 Foamix Ltd. Body cavity foams
WO2008154240A1 (en) * 2007-06-06 2008-12-18 Biohealth Llc Pharmaceutical composition of a new system for vaginal release of steroids
WO2009101182A1 (en) * 2008-02-15 2009-08-20 N.V. Organon Use of etonogestrel for benign prostate hyperplasia (bph).

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2747042B1 (en) 1996-04-05 1998-06-05 Besins Iscovesco Lab PROGESTERONE AND OESTRADIOL-BASED MEDICINE
US20040198706A1 (en) 2003-03-11 2004-10-07 Carrara Dario Norberto R. Methods and formulations for transdermal or transmucosal application of active agents

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4252787A (en) * 1976-12-27 1981-02-24 Cambridge Research And Development Group Anti-fertility composition and method
US20050181045A1 (en) * 1998-11-18 2005-08-18 Ferring Pharmaceuticals, Inc. Vaginally administrable progesterone-containing tablets and method for preparing same
WO2006131784A1 (en) * 2004-04-28 2006-12-14 Foamix Ltd. Body cavity foams
WO2006060462A1 (en) * 2004-12-01 2006-06-08 Johnson & Johnson Consumer Companies, Inc. Compositions and methods of treating irritation and kit therefor
WO2008154240A1 (en) * 2007-06-06 2008-12-18 Biohealth Llc Pharmaceutical composition of a new system for vaginal release of steroids
WO2009101182A1 (en) * 2008-02-15 2009-08-20 N.V. Organon Use of etonogestrel for benign prostate hyperplasia (bph).

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SITRUK-WARE ET AL: "Reprint of Pharmacological profile of progestins", MATURITAS, ELSEVIER SCIENCE PUBLISHERS IRELAND LTD, IR, vol. 61, no. 1-2, 1 September 2008 (2008-09-01), pages 151 - 157, XP025742124, ISSN: 0378-5122, [retrieved on 20081117], DOI: DOI:10.1016/J.MATURITAS.2008.11.011 *
SKOUBY S O ET AL: "Progestins in HRT: Sufferance or desire?", MATURITAS, ELSEVIER SCIENCE PUBLISHERS IRELAND LTD, IR, vol. 62, no. 4, 20 April 2009 (2009-04-20), pages 371 - 375, XP026058465, ISSN: 0378-5122, [retrieved on 20090208], DOI: DOI:10.1016/J.MATURITAS.2008.12.019 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9248136B2 (en) 2011-11-23 2016-02-02 Therapeuticsmd, Inc. Transdermal hormone replacement therapies

Also Published As

Publication number Publication date
WO2011073995A2 (en) 2011-06-23

Similar Documents

Publication Publication Date Title
WO2011073995A3 (en) Liquid vaginal spray of progesterone
WO2010088409A3 (en) Methods of neuroprotection using neuroprotective steroids and a vitamin d
EP2637702A4 (en) Methods, compositions, cells, and kits for treating ischemic injury
CA2849734C (en) Intra-vaginal devices and methods for treating fecal incontinence
GB0820190D0 (en) Tissue excision tool, kits and methods of using the same
EP2120728A4 (en) Replaceable tip suturing device, system, and method for use with differing needles
WO2009089260A3 (en) Combination of anti-ctla4 antibody with tubulin modulating agents for the treatment of proliferative diseases
WO2010111409A3 (en) Pluripotent stem cells
GB0709910D0 (en) Stents, devices for use with stents and method relating thereto
EP2515408A4 (en) Control device for secondary battery, and control method for secondary battery
GB2519273A (en) Aerosol actuators, devices, and methods of making and using the same
EP2266819A4 (en) Method for producing modified conjugated diene polymer/copolymer, modified conjugated diene polymer/copolymer, and rubber composition and tier using the same
EP2396011A4 (en) Fibronectin type iii domain based scaffold compositions, methods and uses
MX2013012971A (en) Stable povidone-iodine compositions with steroids or non-steroidal anti-inflammatories.
WO2011142858A3 (en) Chlorotoxin variants, conjugates, and methods for their use
IL208027A0 (en) Methods, compositions, and kits for treating pain and pruritus
EP2657368B8 (en) Nozzle for cold spray, and cold spray device using nozzle for cold spray
ZA200903715B (en) Compositions, kits and uses for protecting the skin against pathogenic microorganisms
WO2011025190A3 (en) Method for performing cooperative function automatically and device using the same
WO2012025615A3 (en) Process and kit for treating hair
SG2013071303A (en) Methods for preparing composition, sheet comprising the composition and electrode comprising the sheet
ZA201201705B (en) Pregnane derivatives condensed in the 16, 17 position with an n-substituted isoxazolidine ring as anti-inflammatory agents
PL2673345T3 (en) Use of liquid compositions for marking liquid hydrocarbon-based fuels and combustibles, and process for detecting the markers
HUE039011T2 (en) Use of natural extracts of tannin and non-tannin materials for improving soil fertility and providing a starter effect on cultivations.
WO2012129429A3 (en) Transdermal compositions comprising an active agent layer and an active agent conversion layer

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10822876

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10822876

Country of ref document: EP

Kind code of ref document: A2